Hypertension, Vol 17, 798-803, Copyright © 1991 by American Heart Association
DR Singer, ND Markandu, AL Sugden, MA Miller and GA MacGregor
When the function of the renin system is inhibited, blood pressure becomes
more dependent on changes in sodium and water balance. Diuretics alone and
sodium restriction alone are additive to converting enzyme inhibitor
therapy. However, it is not known if these two ways of reducing sodium
balance are additive in the presence of established converting enzyme
inhibition. We therefore performed a double-blind crossover study of the
effects of moderate sodium restriction in 21 patients with essential
hypertension who were already being treated with the combination of a
converting enzyme inhibitor and a diuretic. After 1 month of captopril (50
mg twice daily) and hydrochlorothiazide (25 mg once daily) therapy, with
their usual sodium intake, average supine blood pressure was 147/96 +/- 5/3
(SEM) mm Hg 2 hours after treatment. Patients then reduced their sodium
intake to around 80-100 mmol/day for the remainder of the study. After 2
weeks of sodium restriction, they entered a double-blind, randomized,
crossover study of Slow Sodium (100 mmol sodium/day) compared with Slow
Sodium placebo, while continuing sodium restriction and the above
treatment. During the double-blind study, after 1 month of treatment with
captopril (50 mg twice daily), hydrochlorothiazide (25 mg once daily), and
Slow Sodium placebo, supine blood pressure 2 hours after treatment was
138/88 +/- 4/2 mm Hg (24-hour urinary sodium 104 +/- 11 mmol). After 1
month of captopril (50 mg twice daily), hydrochlorothiazide (25 mg once
daily), and Slow Sodium tablets, supine blood pressure 2 hours after
treatment was 147/91 +/- 5/2 mm Hg (p less than 0.05; 24-hour urinary
sodium 195 +/- 14 mmol).(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide
Department of Medicine I, St. George's Hospital Medical School, London, UK.
This article has been cited by other articles:
![]() |
D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Circulation, June 24, 2008; 117(25): e510 - e526. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension, June 1, 2008; 51(6): 1403 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
S U Shah, S Anjum, and W A Littler Use of diuretics in cardiovascular disease: (2) hypertension Postgrad. Med. J., May 1, 2004; 80(943): 271 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonelli, J. Gill, S. Pandeya, C. Bohm, A. Levin, and B. A. Kiberd Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1426 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Graudal, A. M. Galloe, and P. Garred Effects of Sodium Restriction on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterols, and Triglyceride: A Meta-analysis JAMA, May 6, 1998; 279(17): 1383 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Lardinois Nutritional Factors and Hypertension Arch Fam Med, August 1, 1995; 4(8): 707 - 713. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |